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Abstract EmrE is a multidrug transporter from Escherichia
coli that belongs to the Smr family of small multidrug trans-
porters. The secondary structure of EmrE consists of a four
helical bundle, as judged by di¡erent techniques. EmrE has
been extensively characterized; nevertheless, the membrane to-
pology of EmrE has not been determined yet. Previous work
with a homologous Smr protein provided partial information of
the membrane topology, however the location of the carboxy-
terminus remained inconclusive. In this work we probed the
membrane topology of EmrE, focusing on the carboxy-terminus
of the protein, using two independent approaches. Our results
support a secondary structure where the carboxy-terminus faces
the cytoplasm, while the ¢rst loop faces the periplasm.
( 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Multidrug transporters actively remove toxic compounds
from the cytoplasm of cells. They are widespread from bac-
teria to man and have been associated with multidrug resis-
tance [1,2]. Numerous multidrug transporters have been iden-
ti¢ed to date and based on amino acid sequence similarity,
they were classi¢ed into several protein families [3,4]. The
smallest multidrug transporters belong to the Smr family.
Proteins in this family are V110 amino acids long and ex-
trude various drugs in exchange with protons, thereby render-
ing bacteria resistant to these compounds [5,6].
The most extensively characterized Smr protein is EmrE,
from Escherichia coli. Hydropathic analysis of the EmrE se-
quence predicts four K-helical transmembrane segments. This
model is experimentally supported by Fourier transform infra-
red spectroscopy studies that con¢rm the high K-helicity of
the protein and by high-resolution heteronuclear nuclear mag-
netic resonance analysis [7,8]. The transmembrane segments of
EmrE are tightly packed in the membrane without any con-
tinuous aqueous domain, as was shown by cysteine scanning
experiments [9]. These results suggest the existence of a hydro-
phobic pathway through which the substrates are translo-
cated. EmrE has only one membrane-embedded charged res-
idue, Glu-14, which is conserved throughout the Smr family,
and was shown to be part of a binding site common to pro-
tons and substrates [10,11]. The occupancy of the binding site
by Hþ and substrate is mutually exclusive and provides the
basis of the simplest coupling for two £uxes [12,13].
When studying the mechanism of action of a membrane
protein such as EmrE, it is essential to determine the mem-
brane topology of the protein. This information cannot be
deduced from structural models of the protein that are based
on detergent-solubilized samples of the protein. Moreover,
knowledge of the membrane topology is required in order
to fully understand these structural models. While the mem-
brane topology of EmrE has not been determined before, that
of QacC, a homologue from Staphylococcus aureus, was in-
vestigated by construction and analysis of a series of qacC-
phoA and qacC-lacZ fusions [14]. This work con¢rmed the
basic four-helical bundle model for Smr proteins, however the
data regarding the possible orientation of the carboxy-termi-
nus were not conclusive. To clarify this point we probed the
membrane topology of EmrE, focusing on the carboxy-termi-
nus, as well as the ¢rst loop connecting transmembrane do-
mains (TM) 1 and 2 of the protein.
2. Materials and methods
2.1. Topology studies using sulfhydryl reagents
E. coli strain HMS174 (DE3) (Novagen) and plasmid pT7-7 EmrE-
His were used throughout these experiments. Single cysteine mutants
of EmrE were constructed on a cysteine-less background. All EmrE
mutants used in this study were previously characterized, and all are
functional proteins [9,15,16]. The cells were grown at 37‡C overnight
in minimal medium A supplemented with MgSO4 (0.01%), thiamine
(2.5 Wg/ml), ampicillin (0.1 mg/ml) and MEM amino acid mixture
(Sigma). The next day, the cells were diluted 1:20 into the same
medium without ampicillin, and incubated for an additional 2 h
before expression was induced by the addition of 0.5 mM isopropyl
L-D-thiogalactoside. Two hours later the cells were harvested and
washed at room temperature with Tris^NaCl bu¡er (150 mM NaCl,
15 mM Tris, pH 7.5), and divided into tubes, about 10 ml of cultured
cells per assay. Expression of the NhaA protein was done using the
E. coli strain TA16 harboring the plasmid paxH with the single cys-
teine mutants E241C and H225C, both functional mutants described
before [17].
For reaction with sulfhydryl reagents the cells were incubated with
10 mM of the reagents 2-aminoethyl methanethiosulfonate hydrobro-
mide (MTSEA, Anatrace), or sodium (2-sulfonatoethyl) methanethio-
sulfonate (MTSES, Anatrace) for 10 min at 25‡C with shaking, and
then washed three times with Tris^NaCl bu¡er. Control cells were
incubated as above, without the MTS reagents. Membranes were
prepared from the cells essentially as described before [18], and His-
tagged protein was puri¢ed as described previously [19]. For labeling
with £uorescein-5-maleimide (NEM-£uorescein, Pierce), puri¢ed pro-
tein bound to beads was washed once with Tris^NaCl bu¡er supple-
mented with 0.5% (w/v) sodium dodecyl sulfate (SDS) and 6 M urea.
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The protein was then incubated with the same bu¡er containing
0.5 mM NEM-£uorescein for 20 min at room temperature. To stop
the reaction, it was diluted with the same bu¡er containing L-mercap-
toethanol at a ¢nal concentration of 5 mM. The protein was then
eluted from the beads using 400 mM imidazole, and analyzed by
SDS^polyacrylamide gel electrophoresis (PAGE). Fluorescence label-
ing analysis of the gel was done using a Fuji¢lm LAS-1000 imaging
system and digitally analyzed with Image Gauge 3.46 Fuji¢lm soft-
ware.
2.2. C-terminal orientation studies using INDIA HisProbe-HRP
Right-side-out membrane vesicles (RSO) were prepared by lyso-
zyme^EDTA treatment and osmotic lysis as described [18]. Inside-
out membrane vesicles (ISO) were prepared by passage through a
French pressure cell at 4000 psi [20]. RSO or ISO membranes
(V50 Wg total membrane protein) from cells expressing His-tagged
EmrE or His-tagged NhaA were diluted in 100 Wl Tris^NaCl bu¡er,
and incubated for 1 h at room temperature with the reagent INDIA
HisProbe-HRP (Pierce) at a ¢nal concentration of 40 Wg/ml. The
membranes were then washed twice with the same bu¡er, to remove
unbound probe, and centrifuged at 244 000Ug for 30 min. The mem-
branes were resuspended with the same bu¡er to their initial volume,
and dot-blotted onto nitrocellulose paper, in various dilutions. The
nitrocellulose paper was then dried, and incubated with a blocking
solution for 20 min. Finally, the horseradish peroxidase (HRP) sub-
strate was added, and the signal was detected using a Fuji¢lm LAS-
1000 imaging system. As a control, the addition of the probe was
done after the membranes had been dot-blotted onto the nitrocel-
lulose paper. Membranes from cells expressing EmrE without a His
tag were used as a negative control in these experiments.
3. Results and discussion
The membrane topology of EmrE was studied using two
independent approaches. The ¢rst approach was to probe, in
whole cells, the accessibility of single cysteine residues engi-
neered within a cysteine-less protein, to di¡erent sulfhydryl
reagents. This was done by assaying the ability of these re-
agents to inhibit labeling of the protein with the £uorescent
reagent NEM-£uorescein. More speci¢cally, a set of single
cysteine mutants was constructed on the background of a
cysteine-less EmrE mutant, with cysteines implanted at vari-
ous locations along the ¢rst loop and carboxy-terminus of the
protein. Whole cells expressing these EmrE constructs were
incubated with either MTSEA or MTSES, which have been
shown to be membrane-permeant and -impermeant, respec-
tively [21]. The cells were then washed to eliminate unbound
reagent, membranes were prepared, and the histidine-tagged
EmrE protein was puri¢ed using Ni-NTA beads. The amount
of reagent bound to the protein was estimated by reacting the
puri¢ed denatured protein, bound to beads, with the £uores-
cent sulfhydryl reagent NEM-£uorescein. Results were ob-
tained after analysis of the protein on SDS^PAGE.
As a control, this assay was also carried out with NhaA, a
protein with a known membrane topology [22]. Two single
cysteine mutants of NhaA were assayed, E241C, facing the
cytoplasm, and H225C, facing the periplasm. Whole cells ex-
pressing these mutants were incubated with MTS reagents.
The percentage of free cysteines left after this reaction was
assessed by reaction of the puri¢ed denatured protein with
NEM-£uorescein. The product was analyzed on SDS^PAGE,
examined for £uorescence (Fig. 1A), and labeled with Coo-
massie to determine total protein amounts (Fig. 1B). Residue
241 did not label with NEM-£uorescein since it fully reacted
with the permeant reagent MTSEA, however the labeling after
treatment with impermeant MTSES was practically identical
to that of the control, without MTS treatment (Fig. 1A, left
panel). Residue 225 gave a di¡erent picture, and was not
labeled after treatment with either MTSEA or MTSES, as
expected for a periplasm-facing residue (Fig. 1A, right panel).
The gel was digitized and quanti¢ed for £uorescence levels
and total protein levels. The results for the £uorescence label-
ing were corrected for the relative protein amounts at each
experimental point. The adjusted results are summarized in a
graph (Fig. 1C).
This system was then used for the analysis of EmrE con-
structs, with single cysteine residues engineered throughout
the hydrophilic regions of the cysteine-less protein. The loca-
tion of these cysteines can be viewed in a schematic represen-
tation of EmrE (Fig. 2). The results for these experiments
were analyzed as before, and £uorescence was adjusted for
the total protein level at each point. The results show that
the ¢rst loop of EmrE, containing residues K22 and W31, is
accessible to both permeant and impermeant MTS reagents
and therefore NEM-£uorescein labeling of this loop was sig-
ni¢cantly inhibited (Fig. 3, right side), suggesting this loop
faces the periplasm of the cell. The carboxy-terminus of
EmrE, containing residues N102 and H110, reacted only
with the permeant reagent MTSEA, but not with impermeant
MTSES, as revealed from the NEM-£uorescein labeling pat-
tern (Fig. 3, left side). These results suggest that the carboxy-
terminus of EmrE faces the cytoplasm of the cells.
The location of the carboxy-terminus of EmrE was further
veri¢ed using an independent technique. In this technique we
probed the accessibility of the carboxy-terminal histidine tag
of EmrE to the reagent HisProbe-HRP. This is a nickel-acti-
vated enzyme that binds to histidine tags, and catalyzes a
Fig. 1. Topology of NhaA using MTS reagents. Whole cells express-
ing NhaA single cysteine mutants E241C (left panel) and H225C
(right panel) were reacted with 10 mM of the sulfhydryl reagents
MTSEA or MTSES. To estimate the percentage of free cysteines
left after this reaction, the proteins were puri¢ed using metal chelate
chromatography and labeled with the £uorescent reagent NEM-£uo-
rescein. A: The mutant proteins were analyzed on SDS^PAGE, and
NEM-£uorescein labeling was documented. B: The same gel was
also analyzed for total protein using Coomassie staining. C: The
percentage of NEM-£uorescein labeling relative to a control without
MTS reagents was adjusted to the relative protein level, and plotted
for each mutant. NhaA protein bands were identi¢ed using molecu-
lar size markers, and were not observed when cells harboring plas-
mid alone were used (not shown). The experiments were performed
at least twice. In each experiment, not fewer than three MTS con-
centrations were tested. For the sake of simplicity only one concen-
tration is shown.
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reaction that results in light emission when given an appro-
priate substrate. In these experiments RSO or ISO are incu-
bated with the reagent under native conditions. After the in-
cubation the membranes are washed to remove unbound
probe, and dot-blotted on nitrocellulose paper. Finally sub-
strate for the HRP enzyme is added and the light reaction is
monitored using digital imaging. The results show that while
EmrE in ISO reacts readily with the reagent (Fig. 4, left side),
in RSO it reacts only when the probe is added after blotting
of the membranes, when they are no longer in their native
state (Fig. 4, right side). As a control, this experiment was also
carried out with the membrane protein NhaA, and the results
obtained (Fig. 4) were very similar to those obtained with
EmrE, as expected from the known topology of NhaA [22].
Taken together, these results support a secondary structure
for EmrE where the carboxy-terminus faces the inside of the
cell.
We have determined the three-dimensional structure to
6.5 AQ resolution of EmrE by electron cryo-microscopy of
two-dimensional crystals [23]. The structure obtained was
that of an asymmetric homodimer. However, at the current
resolution of our map we could not directly resolve the iden-
tity of the transmembrane helices. Therefore, two possible
models of EmrE were suggested, one in which the two mono-
mers in the dimer have the same orientation in the membrane,
and a model where the two monomers have opposite orienta-
tions, with inverted topologies. The results we present here
clearly demonstrate that the C-termini and the ¢rst loops of
all the monomers are facing the same side (cytoplasm and
periplasm, respectively), and therefore it is not likely that
the protein has a mixed topology.
In summary, using two independent approaches, this work
demonstrates that the ¢rst loop of EmrE, connecting between
TM1 and TM2, faces the periplasm of cells, while the car-
boxy-terminus of the protein faces the cytoplasm.
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Fig. 2. Location of single cysteines implanted within the EmrE pro-
tein. Model of the secondary structure of EmrE-His, with four
transmembrane regions predicted by hydropathy analysis. Residues
which have been replaced, one at a time, with cysteines are high-
lighted with a dark background, and marked with an arrow bearing
the position number. The six histidine tag and myc epitope linker
are highlighted with a box.
Fig. 3. Topological studies using MTS reagents. Whole cells express-
ing single cysteine mutants of EmrE were reacted with the sulfhy-
dryl reagents MTSEA or MTSES. To estimate the percentage of
free cysteines left after this reaction, the proteins were puri¢ed using
a Ni-NTA column and labeled with the £uorescent reagent NEM-
£uorescein. The mutant proteins were analyzed on SDS^PAGE, and
NEM-£uorescein labeling was measured. The percentage of NEM-
£uorescein labeling relative to a control without MTS reagents was
adjusted to the relative protein level, and plotted for each EmrE
mutant. EmrE protein bands were identi¢ed using molecular size
markers, and were not observed when cells harboring plasmid alone
were used (not shown). The experiments were performed at least
twice. In each experiment, not fewer than three MTS concentrations
were tested. For the sake of simplicity only one concentration is
shown
Fig. 4. The carboxy-terminus of EmrE faces the cytoplasm. RSO
and ISO were prepared from cells expressing histidine-tagged EmrE
or histidine-tagged NhaA. The membranes were probed with the re-
agent INDIA HisProbe-HRP, a nickel-activated enzyme that binds
to histidine tags and catalyzes a reaction that results in light emis-
sion. The probe was incubated with the membrane vesicles before
(left panel) or after (right panel) they had been blotted onto nitro-
cellulose paper. The HRP substrate was added to initiate the light
reaction, and the blot was documented using digital imaging. Mem-
branes expressing EmrE without a histidine tag (Control) served as
a negative control.
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